A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION)
Vaccine（2023）
摘要
ClinicalTrials.gov: NCT03620162; EudraCT: 2018-001151-12.
更多查看译文
关键词
Pneumococcal vaccine,Immunogenicity,Safety,Pediatric
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要